Kisan M Kodam Selected Research

1- biphenyl- 4- yl- 2- (4- nitrophenoxy)ethanone

1/2011	Effect of a novel biphenyl compound, VMNS2e on ob/ob mice.
12/2010	Novel biphenyl compound, VMNS2e, ameliorates streptozotocin-induced diabetic nephropathy in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kisan M Kodam Research Topics

Disease

2	Body Weight (Weight, Body) 01/2011 - 12/2010
1	Breast Neoplasms (Breast Cancer) 09/2021
1	Neoplasms (Cancer) 09/2021
1	Starvation 05/2017
1	Insulin Resistance 01/2011
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2010

Drug/Important Bio-Agent (IBA)

2	1- biphenyl- 4- yl- 2- (4- nitrophenoxy)ethanoneIBA 01/2011 - 12/2010
2	Blood Glucose (Blood Sugar)IBA 01/2011 - 12/2010
1	Poloxamer (Poloxamer 407)IBA 09/2021
1	CurcuminIBA 09/2021
1	MicrogelsIBA 09/2021
1	CarbonIBA 05/2017
1	ArsenicIBA 05/2017
1	arseniteIBA 05/2017
1	oxidized low density lipoproteinIBA 01/2011
1	FructosamineIBA 01/2011
1	CholesterolIBA 01/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2011
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2011
1	Insulin (Novolin)FDA Link 01/2011
1	LipidsIBA 01/2011
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2011
1	Triglycerides (Triacylglycerol)IBA 01/2011
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 12/2010
1	Streptozocin (Streptozotocin)FDA Link 12/2010
1	diphenyl (biphenyl)IBA 12/2010

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 09/2021
1	Glycemic Control 01/2011